Halozyme Therapeutics, Inc.
(NASDAQ : HALO)

( )
HALO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading HALO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.64%68.221.0%$511.57m
AMGNAmgen Inc.
-0.06%164.611.2%$473.08m
BIIBBiogen Inc.
-2.41%279.981.2%$433.18m
CELGCelgene Corporation
-0.26%125.201.1%$368.74m
REGNRegeneron Pharmaceuticals, Inc.
-0.25%371.392.7%$306.45m
VRTXVertex Pharmaceuticals Incorporated
-0.79%116.341.8%$289.18m
INCYIncyte Corporation
-1.05%123.082.1%$252.04m
ALXNAlexion Pharmaceuticals, Inc.
0.15%120.731.6%$213.99m
ILMNIllumina, Inc.
1.70%184.583.3%$188.12m
TSROTESARO, Inc.
2.58%142.0115.3%$145.06m
NBIXNeurocrine Biosciences, Inc.
-0.63%53.284.5%$109.21m
BMRNBioMarin Pharmaceutical Inc.
2.00%96.074.3%$103.70m
KITEKite Pharma, Inc.
2.77%82.8015.6%$98.74m
CLVSClovis Oncology, Inc.
1.35%58.6418.2%$88.77m
AAgilent Technologies, Inc.
0.06%54.841.6%$88.10m

Company Profile

Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.